A new study published in the Journal of the American Medical Association further confirmed the link between hormone replacement therapy (HRT) drugs and breast cancer. According to the study, post-menopausal women who took HRT drugs — estrogen plus progestin — were more likely to develop aggressive and deadly forms of breast cancer. Such women were more likely to die from breast cancer than women who had not been prescribed HRT drugs, like Prempro and Premarin.
I have written previously about the dangers of Prempro, Premarin and other hormone replacement (HRT) drugs.
There has been significant news coverage of this new study linking HRT drugs to fatal breast cancer, including the following:
- Study: Post-Menopausal Hormone Therapy Increases Cancer Risk [PBS Newshour – Video]
- Breast Cancer Risks for Post-Menopausal Women [ABC News – Video]
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women [JAMA]
- Breast Cancer Seen as Riskier With Hormone [Denise Grady at NYT]
- Post-menopausal hormones boost cancer risk, study finds [The Washington Post]
- Pfizer Hormones Almost Double Breast Cancer Death Risk in U.S. Research [Michelle Fay Cortez at Bloomberg News]
- Hormone Replacement, Breast Cancer Link Grows [CBS News]
(c) Copyright 2010 Brett A. Emison
Brett Emison is currently a partner at Langdon & Emison, a firm dedicated to helping injured victims across the country from their primary office near Kansas City. Mainly focusing on catastrophic injury and death cases as well as complex mass tort and dangerous drug cases, Mr. Emison often deals with automotive defects, automobile crashes, railroad crossing accidents (train accidents), trucking accidents, dangerous and defective drugs, defective medical devices.